Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.

@article{Geloneck2014RefractiveOF,
  title={Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.},
  author={Megan M Geloneck and Alice Z. Chuang and William L. Clark and Michael G Hunt and Alan A Norman and Eric A Packwood and Khaled A. Tawansy and Helen A. Mintz-Hittner},
  journal={JAMA ophthalmology},
  year={2014},
  volume={132 11},
  pages={1327-33}
}
IMPORTANCE Children born prematurely who develop retinopathy of prematurity (ROP) often develop myopia, and those who require laser treatment may develop very high myopia, which has considerable clinical consequences. OBJECTIVE To report refractive outcomes in preterm infants who developed ROP in zone I or zone II posterior as stage 3+ ROP or aggressive posterior ROP (APROP). DESIGN, SETTING, AND PARTICIPANTS All infants received intravitreal bevacizumab or laser therapy in a prospective… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 9 times over the past 90 days. VIEW TWEETS
38 Citations
33 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 38 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 33 references

Similar Papers

Loading similar papers…